The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 2.21
All Cancer Sites (Invasive)
United States Cancer Prevalence Estimates
| Race/Ethnicity | Sex | Years Since Diagnosis | Completeh | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 to <5 | 5 to <10 | 10 to <15 | 15 to <20 | 20 to <25 | 25 to <30 | 0 to <20e | 0 to <37e | >=37g | |||
| All Races b | Both Sexes | 4,660,390 | 3,220,696 | 2,297,725 | 1,454,626 | 861,141 | 505,137 | 12,037,276 | 13,405,317 | 370,934 | 13,776,251 |
| Males | 2,395,057 | 1,636,053 | 1,105,506 | 654,928 | 315,984 | 163,447 | 5,951,188 | 6,387,558 | 76,971 | 6,464,529 | |
| Females | 2,265,333 | 1,584,643 | 1,192,219 | 799,698 | 545,157 | 341,690 | 6,086,088 | 7,017,759 | 293,963 | 7,311,722 | |
| White b | Both Sexes | 3,913,280 | 2,780,192 | 2,013,548 | 1,287,998 | 779,233 | 458,563 | 10,359,308 | 11,601,795 | 324,151 | 11,925,946 |
| Males | 2,003,404 | 1,405,324 | 962,849 | 578,882 | 289,312 | 150,214 | 5,096,308 | 5,497,887 | 72,025 | 5,569,912 | |
| Females | 1,909,876 | 1,374,868 | 1,050,699 | 709,116 | 489,921 | 308,349 | 5,263,000 | 6,103,908 | 252,126 | 6,356,034 | |
| Black b | Both Sexes | 487,189 | 296,165 | 190,445 | 110,608 | 52,052 | 29,576 | 1,109,887 | 1,189,165 | 22,527 | 1,211,692 |
| Males | 261,563 | 162,329 | 101,649 | 53,718 | 17,259 | 7,999 | 588,391 | 609,432 | 1,907 | 611,339 | |
| Females | 225,626 | 133,836 | 88,796 | 56,890 | 34,793 | 21,577 | 521,496 | 579,733 | 20,620 | 600,353 | |
| Asian/ Pacific Islander c |
Both Sexes | 147,701 | 90,366 | 58,598 | + | + | + | 330,690 | + | + | + |
| Males | 62,926 | 37,188 | 22,375 | + | + | + | 134,340 | + | + | + | |
| Females | 84,775 | 53,178 | 36,223 | + | + | + | 196,350 | + | + | + | |
| Hispanic d | Both Sexes | 327,526 | 204,575 | 131,420 | + | + | + | 742,005 | + | + | + |
| Males | 155,663 | 95,961 | 59,027 | + | + | + | 342,644 | + | + | + | |
| Females | 171,863 | 108,614 | 72,393 | + | + | + | 399,361 | + | + | + | |
| Race/Ethnicity | Sex | Age Specific (Crude) | Age-Adjustedf | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Ages | 0-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | 80+ | All Ages | ||
| All Races c | Both Sexes | 3.3439% | 0.0867% | 0.1870% | 0.3323% | 0.7825% | 1.9172% | 4.3781% | 9.4329% | 15.9290% | 17.8982% | 3.2158% |
| Males | 3.3276% | 0.0907% | 0.1973% | 0.3215% | 0.6175% | 1.3317% | 3.5697% | 10.0706% | 20.3717% | 25.5905% | 3.5875% | |
| Females | 3.3597% | 0.0826% | 0.1762% | 0.3436% | 0.9482% | 2.4979% | 5.1523% | 8.8564% | 12.3280% | 13.3496% | 3.0004% | |
| White c | Both Sexes | 3.6851% | 0.0946% | 0.2067% | 0.3762% | 0.8788% | 2.0546% | 4.5798% | 9.8605% | 16.7896% | 18.5683% | 3.3871% |
| Males | 3.6345% | 0.0977% | 0.2199% | 0.3648% | 0.7023% | 1.4504% | 3.7052% | 10.3218% | 21.0546% | 26.0188% | 3.7143% | |
| Females | 3.7355% | 0.0914% | 0.1929% | 0.3884% | 1.0646% | 2.6790% | 5.4452% | 9.4296% | 13.2452% | 14.1132% | 3.2085% | |
| Black c | Both Sexes | 2.5129% | 0.0631% | 0.1280% | 0.2137% | 0.5347% | 1.5799% | 4.1368% | 9.8340% | 15.9616% | 16.0571% | 3.0533% |
| Males | 2.7904% | 0.0677% | 0.1266% | 0.2103% | 0.3830% | 1.1080% | 4.0489% | 12.8776% | 24.1031% | 27.6383% | 4.0581% | |
| Females | 2.2601% | 0.0582% | 0.1294% | 0.2170% | 0.6672% | 1.9962% | 4.2134% | 7.4455% | 10.2639% | 10.4330% | 2.4333% | |
| Asian/ Pacific Islander c |
Both Sexes | 2.1407% | 0.0676% | 0.1360% | 0.2033% | 0.4844% | 1.3780% | 3.1398% | 5.8799% | 9.8282% | 12.7380% | 2.1271% |
| Males | 1.8597% | 0.0748% | 0.1430% | 0.1837% | 0.3286% | 0.7281% | 1.9350% | 5.2145% | 11.7196% | 17.9383% | 2.1145% | |
| Females | 2.3981% | 0.0600% | 0.1287% | 0.2229% | 0.6243% | 1.9531% | 4.1756% | 6.4300% | 8.3655% | 9.5615% | 2.1951% | |
| Hispanic d | Both Sexes | 1.4540% | 0.0814% | 0.1769% | 0.2627% | 0.5666% | 1.3533% | 3.1080% | 6.6182% | 11.5132% | 13.4762% | 2.3397% |
| Males | 1.3163% | 0.0864% | 0.1864% | 0.2626% | 0.4401% | 0.8479% | 2.2370% | 6.7085% | 15.3104% | 20.1082% | 2.6149% | |
| Females | 1.5950% | 0.0763% | 0.1670% | 0.2628% | 0.7018% | 1.8807% | 3.9425% | 6.5406% | 8.7002% | 9.5071% | 2.2195% | |
Footnotes:
a US 2012 cancer prevalence counts are based on 2012 cancer prevalence proportions from the SEER registries and 1/1/2012 US population estimates based on the average of 2011 and 2012 population estimates from the US Bureau of the Census. Prevalence was calculated using the First Malignant Primary Only for a person.
b Statistics based on SEER 9 Areas.
c Statistics based on SEER 11 Areas and Rural Georgia
d Statistics based on NHIA for Hispanic for SEER 11 Areas and Rural Georgia.
e Maximum limited-duration prevalence: 37 years for 1975-2012 SEER 9 data; 20 years for 1992-2012 SEER 11 data (used to calculate prevalence for Hispanics and Asian Pacific Islanders).
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.
g Cases diagnosed more than 37 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).
h Complete prevalence is obtained by summing 0 to <37 and >=37.
i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.
- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.
+ Not available.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.